HLA-DRA Antikörper (AA 26-221)
-
- Target Alle HLA-DRA Antikörper anzeigen
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Bindungsspezifität
- AA 26-221
-
Reaktivität
- Kaninchen
-
Wirt
-
Meerschweinchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLA-DRA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
- Sequenz
- MGHHHHHHSG S- AIKEE HVIIQAEYFL SPDDLGEFMF DFDGDEIFHV DMDKKETVWR LKEFGQFASF EAQGALANIA VDRANLDIMI KRSNHTPDTN VPPEVTLLPS SPVELGEPNV LICFIDKFSP PVINVTWLRN GNPVTMGVSE TVFLPRDDHL FRKFHYLPFL PSTEDVYDCK VEHWGLEEPT LKHWEFEART PLPETTENVV C
- Spezifität
- The antibody is a cavia polyclonal antibody raised against HLA-DRA. It has been selected for its ability to recognize HLA-DRA in immunohistochemical staining and western blotting.
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) corresdonding to Ala26~Cys221 (Accession # NM_001171118.1)
- Isotyp
- IgG
- Top Product
- Discover our top product HLA-DRA Primärantikörper
-
-
- Applikationshinweise
-
Western blotting: 0.5-5 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Andere Bezeichnung
- HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA Produkte)
- Synonyme
- HLA-DRA1 antikoerper, MLRW antikoerper, DR-alpha antikoerper, HLA-DRA antikoerper, Mamu-DRA1 antikoerper, major histocompatibility complex, class II, DR alpha L homeolog antikoerper, major histocompatibility complex, class II, DR alpha antikoerper, hla-dra.L antikoerper, HLA-DRA antikoerper, MAMU-DRA antikoerper, BOLA-DRA antikoerper
- Hintergrund
- MHCDRa, HLADRa, Major Histocompatibility Complex Class II DR Alpha
- Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events
-